Acrospire Investment Management LLC - ONCOMED PHARMACEUTICALS INC ownership

ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 86 filers reported holding ONCOMED PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.

Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of ONCOMED PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$101,000
+818.2%
13,122
+1346.7%
0.04%
+425.0%
Q2 2016$11,0009070.01%
Other shareholders
ONCOMED PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
BVF INC/IL 4,400,289$19,889,0002.53%
ADAMS STREET PARTNERS LLC 1,473,061$6,658,0001.70%
Iguana Healthcare Management, LLC 700,000$3,164,0000.87%
Perceptive Advisors 2,076,578$9,386,0000.18%
Birchview Capital, LP 28,689$130,0000.07%
Cannell & Co. 303,971$1,374,0000.05%
ELEMENT CAPITAL MANAGEMENT LLC 25,249$114,0000.05%
NJ State Employees Deferred Compensation Plan 38,000$172,0000.03%
DISCIPLINED GROWTH INVESTORS INC /MN 313,775$1,418,0000.03%
Candriam S.C.A. 370,000$1,672,0000.03%
View complete list of ONCOMED PHARMACEUTICALS INC shareholders